https://www.selleckchem.com/pr....oducts/prostaglandin
Acute bronchiolitis treatment guidelines changed in Norway in 2013, no longer recommending the use of nebulised epinephrine. We aimed to assess whether these changes were successfully implemented in both primary and secondary care. Secondary aims were to compare the difference in management of acute bronchiolitis patients in primary and secondary care between 2009 and 2017. We retrospectively registered data on demographics, clinical features and management from electronic medical records of all infants (12 months